Differential Expression Levels of MRP1, MRP4, and MRP5 in Response to Human Immunodeficiency Virus Infection in Human Macrophages

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 5, 2004, Pages 1889-1891

  Jorajuria, Sylvie ^a   Dereuddre Bosquet, Nathalie ^a   Naissant Storck, Karen ^a   Dormont, Dominique ^a   Clayette, Pascal ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; INTERLEUKIN 6; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 4; MULTIDRUG RESISTANCE PROTEIN 5; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DRUG TRANSPORT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MACROPHAGE; MONOCYTE; MRP1 GENE; MRP4 GENE; MRP5 GENE; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS GENE;

GLYCERALDEHYDE 3-PHOSPHATE DEHYDROGENASE (NADP+); HIV INFECTIONS; HUMANS; INTERLEUKIN-6; MACROPHAGES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RIBOSOMAL PROTEINS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 2142662130     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.5.1889-1891.2004     Document Type: Article

References (18)

1. Benveniste, O., M. Martin, F. Villinger, and D. Dormont. 1998. Techniques for quantification of cytokine mRNAs. Cytokines Cell. Mol. Ther. 4:207-214.
2. Borst, P., R. Evers, M. Kool, and J. Wijnholds. 1999. The multidrug resistance protein family. Biochim. Biophys. Acta 1461:347-357.
3. Dereuddre-Bosquet, N., P. Clayette, M. Martin, O. Benveniste, P. Fretier, P. Jaccard, B. Vaslin, A. Lebeaut, and D. Dormont. 1997. Lack of interleukin 10 expression in monocyte-derived macrophages in response to in vitro infection by HIV type 1 isolates. AIDS Res. Hum. Retrovir. 13:961-966.
4. Holzmeister, J., B. Ludewig; G. Pauli, and D. Simon. 1993. Sequence specific binding of the transcription factor c-Etsl to the human immunodeficiency virus type I long terminal repeat. Biochem. Biophys. Res. Commun. 197:1229-1233.
5. Juliger, S., M. Bongartz, A. J. Luty, P. G. Kremsner, and J. F. Kun. 2003. Functional analysis of a promoter variant of the gene encoding the interfer-on-gamma receptor chain I. Immunogenetics 54:675-680.
6. Laupeze, B., L. Amiot, L. Payen, B. Drenou, J. M. Grosset, G. Lehne, R. Faucbet, and O. Fardel. 2001. Multidrug resistance protein (MRP) activity in normal mature leukocytes and CD34-positive hematopoietic cells from peripheral blood. Life Sci. 68:1323-1331.
7. Lee, G., and M. Piquette-Miller. 2001. Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. Can. J. Physiol. Pharmacol. 79:876-884.
8. Legrand, O., J. Y. Perrot, R. Tang, G. Simonin, S. Gurbuxani, R. Zittoun, and J. P. Marie. 1996. Expression of the multidrug resistance-associated protein (MRP) mRNA and protein in normal peripheral blood and bone marrow haemopoietic cells. Br. J. Haematol. 94:23-33.
9. Meaden, E. R., P. G. Hoggard, B. Maber, S. H. Khoo, and D. J. Back. 2001. Expression of P-glycoprotein and multidrug resistance-associated protein in healthy volunteers and HIV-infected patients. AIDS Res. Hum. Retrovir. 17:1329-1332.
10. Posada, R., M. Pettoello-Mantovani, M. Sieweke, T. Graf, and H. Goldstein. 2000. Suppression of HIV type 1 replication by a dominant-negative Ets-1 mutant. AIDS Res. Hum. Retrovir. 16:1981-1989.
11. Reid, G., P. Wielinga, N. Zelcer, M. De Haas, L. Van Deemter, J. Wijnholds, J. Balzarini, and P. Borst. 2003. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5. Mol. Pharmacol. 63:1094-1103.
12. +-dependent high-affinity glutamate transport in macrophages. J. Immunol. 164:5430-5438.
13. Sampath, J., M. Adachi, S. Hatse, L. Naesens, J. Balzarini, R. M. Flatley, L. H. Matherly, and J. D. Schuetz. 2002. Role of MRP4 and MRP5 in biology and chemotherapy. AAPS Pharm. Sci. 4:14.
14. Schuetz, J. D., M. C. Connelly, D. Sun, S. G. Paibir, P. M. Flynn, R. V. Srinivas, A. Kumar, and A. Fridland. 1999. MRP4: a previously unidentified factor in resistance to nucleoside-based antiviral drugs. Nat. Med. 5:1048-1051.
15. Speck, R. R., X. F. Yu, J. Hildreth, and C. Flexner. 2002. Differential effects of p-glycoprotein and multidrug resistance protein-1 on productive human immunodeficiency virus infection. J. Infect. Dis. 186:332-340.
16. Srinivas, R. V., D. Middlemas, P. Flynn, and A. Fridland. 1998. Human immunodeficiency virus protease inhibitors serve as substrates for multi-drug transporter proteins MDR1 and MRP1 but retain antiviral efficacy in cell lines expressing these transporters. Antimicrob. Agents Chemother. 42:3157-3162.
17. Wang, Q., and W. T. Beck. 1998. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Cancer Res. 58:5762-5769.
18. Wingender, E., X. Chen, E. Fricke, R. Geffers, R. Hehl, I. Liebich, M. Krull, V. Matys, H. Michael, R. Ohnhauser, M. Pruss, F. Schacherer, S. Thiele, and S. Urbach. 2001. The TRANSFAC system on gene expression regulation. Nucleic Acids Res. 29:281-283.